Thr713

Site Information
DAVARKAtKPMAEsP SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 11129731

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 2 ) , Jurkat (T lymphocyte) ( 1 )

References
1	Possemato A (2010) CST Curation Set: 10782; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Curated Info
2	Zhou J (2009) CST Curation Set: 7599; Year: 2009; Biosample/Treatment: cell line, HeLa/untreated; Disease: cervical adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P Curated Info